Literature DB >> 19038330

Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart.

Tao Li1, Jing Li, Jin Liu, Pu Zhang, Wei Wu, Ronghua Zhou, Guohua Li, Wensheng Zhang, Mingliang Yi, Han Huang.   

Abstract

Ischemia/reperfusion (I/R) injury mainly caused by oxidative stress plays a major role in cardiac damage. The extent of the I/R injury is also an important factor that determines the function of a transplanted heart. This study first examined whether hemoglobin-based oxygen carriers (HBOCs) could protect isolated rat heart from I/R injury and then elucidated the underlying mechanism. Using the Langendorff model, isolated Sprague-Dawley rat hearts were arrested and stored at 4 degrees C for 8 h and then reperfused for 2 h. Compared with St. Thomas' solution (STS) and rat self blood in STS, polymerized placenta hemoglobin (PolyPHb) in STS greatly improved heart contraction and decreased infarction size. The extent of myocardial apoptosis was also significantly decreased, which was related to reduced iNOS-derived nitric oxide production, increased protein ratio of Bcl-2/Bax, and reduced caspase-3 activity and cleavage level. Furthermore, PolyPHb in STS did not increase malondialdehyde, peroxynitrite, or mitochondrial hydrogen peroxide formation, but greatly elevated superoxide dismutase activity and preserved mitochondrial ATP synthesis, which served to maintain redox homeostasis in I/R heart. In conclusion, our results demonstrate that HBOCs protected isolated heart from I/R injury and this protection was associated with attenuation of NO-mediated myocardial apoptosis and restoration of the nitroso-redox balance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038330     DOI: 10.1016/j.freeradbiomed.2008.10.042

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin.

Authors:  Tao Li; Ronghua Zhou; Yusheng Yao; Qian Yang; Cheng Zhou; Wei Wu; Qian Li; Zhen You; Xiaolin Zhao; Linhui Yang; Chen Li; Da Zhu; Yanhua Qiu; Ming Luo; Zhaoxia Tan; Huan Li; Yanfang Chen; Gu Gong; Yuan Feng; Ke Dian; Jin Liu
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

2.  Gastric antisecretory and antiulcer activity of bovine hemoglobin.

Authors:  Abdulrahman K Al Asmari; Saud Al Omani; Ibrahim Elfaki; Mohammad Tariq; Ahmed Al Malki; Saeed Al Asmary
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

3.  Emergent role of gasotransmitters in ischemia-reperfusion injury.

Authors:  Bridgette F Moody; John W Calvert
Journal:  Med Gas Res       Date:  2011-04-27

Review 4.  Antioxidant enzymes as redox-based biomarkers: a brief review.

Authors:  Hee-Young Yang; Tae-Hoon Lee
Journal:  BMB Rep       Date:  2015-04       Impact factor: 4.778

5.  High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery.

Authors:  Qian Yang; Wei Wu; Qian Li; Chan Chen; Ronghua Zhou; Yanhua Qiu; Ming Luo; Zhaoxia Tan; Shen Li; Gang Chen; Wentao Zhou; Jiaxin Liu; Chengmin Yang; Jin Liu; Tao Li
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

Review 6.  Hemoglobin-Based Oxygen Carriers: Potential Applications in Solid Organ Preservation.

Authors:  Min Cao; Guoqing Wang; Hongli He; Ruiming Yue; Yong Zhao; Lingai Pan; Weiwei Huang; Yang Guo; Tao Yin; Lina Ma; Dingding Zhang; Xiaobo Huang
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

7.  Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.

Authors:  Liming Yu; Zhi Li; Xue Dong; Xiaodong Xue; Yu Liu; Shu Xu; Jian Zhang; Jinsong Han; Yang Yang; Huishan Wang
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.